Skip to main content
Clinical Trials/CTRI/2023/08/056246
CTRI/2023/08/056246Not yet recruitingPhase 2

Effect of Ferrous Ascorbate versus Liposomal iron on hemoglobinConcentration and Iron indices in 6 to 59 months age Children With Nutritional Iron-Deficiency Anemia:A Double blinded single centre Randomized clinical trial - Nil

amita Mishra0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Children in the age group 6 to 59 months with Iron Deficiency Anaemia as confirmed by hematological parameters

Exclusion Criteria

  • 1. Subjects with other causes of anemia(hemolytic anemia, bone marrow failure) as evidenced by
  • clinical symptoms and signs and or laboratory values
  • 2. Subjects with ongoing blood loss
  • 3. Subjects who have received any iron therapy or blood transfusion in the past 3 months
  • 4. Subjects with disease interfering with iron absorption e.g. Inflammatory bowel disease, celiac
  • disease, bowel surgery, chronic gastrointestinal infection
  • 5. Subjects with serious chronic medical conditions like chronic kidney disease, congenital heart disease, and chronic lung disease.
  • 6. Subjects with prior history of allergy to iron preparations

Investigators

Sponsor
amita Mishra

Similar Trials

A study to compare liposomal iron with... | Clinical Trial